Literature DB >> 18322014

Txnip balances metabolic and growth signaling via PTEN disulfide reduction.

Simon T Y Hui1, Allen M Andres, Amber K Miller, Nathanael J Spann, Douglas W Potter, Noah M Post, Amelia Z Chen, Sowbarnika Sachithanantham, Dae Young Jung, Jason K Kim, Roger A Davis.   

Abstract

Thioredoxin-interacting protein (Txnip) inhibits thioredoxin NADPH-dependent reduction of protein disulfides. Total Txnip knockout (TKO) mice adapted inappropriately to prolonged fasting by shifting fuel dependence of skeletal muscle and heart from fat and ketone bodies to glucose. TKO mice exhibited increased Akt signaling, insulin sensitivity, and glycolysis in oxidative tissues (skeletal muscle and hearts) but not in lipogenic tissues (liver and adipose tissue). The selective activation of Akt in skeletal muscle and hearts was associated with impaired mitochondrial fuel oxidation and the accumulation of oxidized (inactive) PTEN, whose activity depends on reduction of two critical cysteine residues. Whereas muscle- and heart-specific Txnip knockout mice recapitulated the metabolic phenotype exhibited by TKO mice, liver-specific Txnip knockout mice were similar to WT mice. Embryonic fibroblasts derived from knockout mice also accumulated oxidized (inactive) PTEN and had elevated Akt phosphorylation. In addition, they had faster growth rates and increased dependence on anaerobic glycolysis due to impaired mitochondrial fuel oxidation, and they were resistant to doxorubicin-facilitated respiration-dependent apoptosis. In the absence of Txnip, oxidative inactivation of PTEN and subsequent activation of Akt attenuated mitochondrial respiration, resulting in the accumulation of NADH, a competitive inhibitor of thioredoxin NADPH-reductive activation of PTEN. These findings indicate that, in nonlipogenic tissues, Txnip is required to maintain sufficient thioredoxin NADPH activity to reductively reactivate oxidized PTEN and oppose Akt downstream signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322014      PMCID: PMC2268825          DOI: 10.1073/pnas.0800293105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  The phosphoinositide 3-kinase pathway.

Authors:  Lewis C Cantley
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

2.  Reversible inactivation of the tumor suppressor PTEN by H2O2.

Authors:  Seung-Rock Lee; Kap-Seok Yang; Jaeyul Kwon; Chunghee Lee; Woojin Jeong; Sue Goo Rhee
Journal:  J Biol Chem       Date:  2002-03-26       Impact factor: 5.157

3.  Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin.

Authors:  P Christian Schulze; Gilles W De Keulenaer; Jun Yoshioka; Kimberly A Kassik; Richard T Lee
Journal:  Circ Res       Date:  2002-10-18       Impact factor: 17.367

Review 4.  PTEN and myotubularin: novel phosphoinositide phosphatases.

Authors:  T Maehama; G S Taylor; J E Dixon
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 5.  Regulatory roles of thioredoxin in oxidative stress-induced cellular responses.

Authors:  Y Nishinaka; H Masutani; H Nakamura; J Yodoi
Journal:  Redox Rep       Date:  2001       Impact factor: 4.412

6.  Model mice for tissue-specific deletion of the manganese superoxide dismutase (MnSOD) gene.

Authors:  Takashi Ikegami; Yo-ichi Suzuki; Takahiko Shimizu; Kyo-ichi Isono; Haruhiko Koseki; Takuji Shirasawa
Journal:  Biochem Biophys Res Commun       Date:  2002-08-23       Impact factor: 3.575

7.  Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP.

Authors:  Steven F Goldberg; Mary E Miele; Naohito Hatta; Minoru Takata; Carrie Paquette-Straub; Leonard P Freedman; Danny R Welch
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

8.  Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance.

Authors:  Jie An; Deborah M Muoio; Masakazu Shiota; Yuka Fujimoto; Gary W Cline; Gerald I Shulman; Timothy R Koves; Robert Stevens; David Millington; Christopher B Newgard
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

9.  Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals.

Authors:  To Yuen Hui; Sonal S Sheth; J Matthew Diffley; Douglas W Potter; Aldons J Lusis; Alan D Attie; Roger A Davis
Journal:  J Biol Chem       Date:  2004-03-26       Impact factor: 5.157

10.  Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.

Authors:  Hyo-Jeong Kim; Takamasa Higashimori; So-Young Park; Hyejeong Choi; Jianying Dong; Yoon-Jung Kim; Hye-Lim Noh; You-Ree Cho; Gary Cline; Young-Bum Kim; Jason K Kim
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

View more
  101 in total

1.  The arrestin domain-containing 3 protein regulates body mass and energy expenditure.

Authors:  Parth Patwari; Valur Emilsson; Eric E Schadt; William A Chutkow; Samuel Lee; Alessandro Marsili; Yongzhao Zhang; Radu Dobrin; David E Cohen; P Reed Larsen; Ann Marie Zavacki; Loren G Fong; Stephen G Young; Richard T Lee
Journal:  Cell Metab       Date:  2011-10-06       Impact factor: 27.287

Review 2.  Physiological insights gained from gene expression analysis in obesity and diabetes.

Authors:  Mark P Keller; Alan D Attie
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

3.  Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP.

Authors:  Liangliang Shen; John M O'Shea; Mohan R Kaadige; Stéphanie Cunha; Blake R Wilde; Adam L Cohen; Alana L Welm; Donald E Ayer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

4.  Ras Suppresses TXNIP Expression by Restricting Ribosome Translocation.

Authors:  Zhizhou Ye; Donald E Ayer
Journal:  Mol Cell Biol       Date:  2018-09-28       Impact factor: 4.272

5.  Deletion of thioredoxin-interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury.

Authors:  M F El-Azab; B R B Baldowski; B A Mysona; A Y Shanab; I N Mohamed; M A Abdelsaid; S Matragoon; K E Bollinger; A Saul; A B El-Remessy
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

6.  Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.

Authors:  Umut Arslan; Emin Özmert; Sibel Demirel; Firdevs Örnek; Figen Şermet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-15       Impact factor: 3.117

7.  AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1.

Authors:  Ning Wu; Bin Zheng; Adam Shaywitz; Yossi Dagon; Christine Tower; Gary Bellinger; Che-Hung Shen; Jennifer Wen; John Asara; Timothy E McGraw; Barbara B Kahn; Lewis C Cantley
Journal:  Mol Cell       Date:  2013-02-28       Impact factor: 17.970

8.  Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice.

Authors:  Tauheed Ishrat; Islam N Mohamed; Bindu Pillai; Sahar Soliman; Abdelrahman Y Fouda; Adviye Ergul; Azza B El-Remessy; Susan C Fagan
Journal:  Mol Neurobiol       Date:  2014-06-18       Impact factor: 5.590

Review 9.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

10.  TXNIP regulates myocardial fatty acid oxidation via miR-33a signaling.

Authors:  Junqin Chen; Martin E Young; John C Chatham; David K Crossman; Louis J Dell'Italia; Anath Shalev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-03       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.